The pandemic has been a blessing and a curse for Sandoz's antibiotics business.
While the demand for antibiotics has generally fallen during the pandemic due to the drastic reduction in the number of surgical procedures, which also affected Sandoz's sales figures, it also caused challenges for the global supply chain, which has helped the generics manufacturer.
More from MedWatch
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.